Endophina ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.7% 1.7% 1.7% 1.7% 1.7%  
Bankruptcy risk  8.6% 9.8% 10.2% 12.4% 5.7%  
Credit score (0-100)  28 24 23 18 40  
Credit rating  BB BB BB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  452 273 1,189 740 720  
EBITDA  239 -122 5.6 -214 140  
EBIT  227 -134 -1.3 -214 135  
Pre-tax profit (PTP)  227.4 -136.1 -7.6 -221.2 93.3  
Net earnings  177.3 -106.1 -6.5 -221.2 93.3  
Pre-tax profit without non-rec. items  227 -136 -7.6 -221 93.3  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  18.7 6.9 0.0 0.0 9.1  
Shareholders equity total  259 3.0 -2.1 -120 374  
Interest-bearing liabilities  0.0 150 0.0 455 200  
Balance sheet total (assets)  444 245 270 348 608  

Net Debt  -269 52.0 -83.3 272 -231  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  452 273 1,189 740 720  
Gross profit growth  128.6% -39.6% 335.4% -37.8% -2.7%  
Employees  1 1 3 2 3  
Employee growth %  0.0% 0.0% 200.0% -33.3% 50.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  444 245 270 348 608  
Balance sheet change%  55.3% -45.0% 10.3% 29.1% 74.7%  
Added value  239.2 -122.2 5.6 -206.7 139.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -24 -24 -14 0 5  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 -1.0 -2.0 -3.0 1.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  50.3% -49.1% -0.1% -28.9% 18.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  62.6% -38.6% -0.5% -57.7% 25.3%  
ROI %  116.7% -64.6% -1.8% -93.8% 22.7%  
ROE %  90.7% -81.0% -4.7% -71.6% 25.8%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  58.3% 1.2% -0.8% -25.6% 61.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -112.4% -42.6% -1,490.2% -127.5% -165.6%  
Gearing %  0.0% 5,013.1% 0.0% -380.4% 53.5%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 3.9% 8.2% 3.4% 13.1%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  2.0 0.7 1.7 3.0 8.3  
Current Ratio  2.0 0.7 1.7 3.0 8.3  
Cash and cash equivalent  268.8 98.2 83.3 182.9 431.1  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  181.6 -62.7 84.4 194.6 475.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  239 -122 2 -103 47  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  239 -122 2 -107 47  
EBIT / employee  227 -134 -0 -107 45  
Net earnings / employee  177 -106 -2 -111 31